Cancer, biosimilar drug maker Coherus shedding more biotech jobs

Coherus is expected to launch a biosimilar of the rheumatoid arthritis drug Humira and recently won FDA approval of its autoinjector product for cancer patients with anemia.

Source: bizjournals.com Health Care:Physician Practices headlines - March 10, 2023 Category: American Health Authors: Ron Leuty Source Type: news